Recursion Pharmaceuticals, Inc. RXRX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s cash ratio?
- Recursion Pharmaceuticals, Inc. (RXRX) reported cash ratio of 5.1× in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s cash ratio increased by 43.0% year-over-year, from 3.6× to 5.1×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s cash ratio has grown at a -15.1% compound annual growth rate (CAGR), from 11.6× to 5.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.